• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 3. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962

Professional Introduction to N-(2-Carboxyethyl)-N-dodecyl-beta-alanine (CAS No. 17066-08-9)

N-(2-Carboxyethyl-N-dodecyl-beta-alanine) is a specialized compound with significant applications in the field of chemical and biomedical research. This compound, identified by its CAS number 17066-08-9, has garnered attention due to its unique structural properties and potential utility in various scientific and industrial applications. The introduction will delve into the compound's chemical characteristics, its synthesis, and its emerging roles in contemporary research.

The molecular structure of N-(2-Carboxyethyl-N-dodecyl-beta-alanine) consists of a beta-alanine backbone, modified with a 2-carboxyethyl group at one end and a dodecyl chain at the other. This configuration imparts unique solubility and reactivity properties, making it a valuable candidate for drug delivery systems, surface modifications, and biomaterial engineering. The dodecyl chain enhances hydrophobic interactions, while the carboxyethyl group provides a site for further functionalization, enabling diverse chemical modifications.

In recent years, the compound has been explored in the development of novel biomaterials. Its ability to form stable complexes with biological molecules has opened doors for applications in tissue engineering and drug encapsulation. For instance, researchers have utilized N-(2-Carboxyethyl-N-dodecyl-beta-alanine) to create biocompatible coatings for medical implants, which exhibit improved biostability and reduced immune responses. These advancements highlight the compound's potential in enhancing the performance of medical devices and improving patient outcomes.

The synthesis of N-(2-Carboxyethyl-N-dodecyl-beta-alanine) involves a multi-step process that requires precise control over reaction conditions. Typically, beta-alanine serves as the starting material, followed by ethylation at the 2-position to introduce the carboxyethyl group. Subsequently, a dodecyl halide is introduced via nucleophilic substitution to complete the molecule. The synthesis must be carefully optimized to ensure high yield and purity, as impurities can significantly affect the compound's functionality.

Recent studies have also explored the use of N-(2-Carboxyethyl-N-dodecyl-beta-alanine) in nanotechnology applications. Its amphiphilic nature allows it to self-assemble into micelles or vesicles, which can be used for drug delivery. These nanostructures can encapsulate hydrophobic drugs and release them in a controlled manner, improving therapeutic efficacy. Moreover, the compound's stability under various conditions makes it suitable for industrial applications, such as corrosion inhibitors or surfactants.

The compound's potential in pharmaceutical research is another area of active investigation. Researchers have examined its interactions with biological targets, including enzymes and receptors, to explore its role in drug development. For example, studies have shown that derivatives of N-(2-Carboxyethyl-N-dodecyl-beta-alanine) can modulate enzyme activity by acting as competitive inhibitors or substrates. This capability could lead to the development of new therapeutic agents targeting specific disease pathways.

The environmental impact of using N-(2-Carboxyethyl-N-dodecyl-beta-alanine) has also been considered in recent research. Studies have assessed its biodegradability and toxicity profile to ensure its safe use in industrial and biomedical applications. The compound has been found to exhibit low toxicity and moderate biodegradability under controlled conditions, making it an environmentally friendly option for various applications.

In conclusion, N-(2-Carboxyethyl-N-dodecyl-beta-alanine) (CAS No. 17066-08-9) is a versatile compound with broad applications in chemical biology and material science. Its unique structural features enable its use in drug delivery systems, biomaterial engineering, nanotechnology, and pharmaceutical research. As ongoing research continues to uncover new properties and applications of this compound, it is expected to play an increasingly important role in advancing scientific and industrial technologies.

• 76234-38-3(3-Pyrrolidin-1-ylpropanoic Acid)
• 1462-54-0(3-Dodecylaminopropionic acid)
• 26371-07-3(1-Piperidinepropanoic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)